• レポートコード:GIR201114823 • 出版社/出版日:GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、109ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、ファージセラピーの世界市場を調査対象にし、ファージセラピーの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(経口、外用、外科的治療)、用途別分析(人間医学、獣医学、農業)、市場予測(2021年~2025年)情報などを整理しました。 ・市場概要 ・企業情報:Phage International、Intralytix、C3J Therapeutics、Adaptive Phage Therapeutics、iNtODEWorld、AmpliPhi Biosciences、Phagomed、InnoPhage、Enbiotix、Locus Biosciences、Pherecydes Pharma、Phagelux、TechnoPhage、Eligo Bioscience ・企業別売上、市場シェア ・ファージセラピーの地域別市場分析 ・ファージセラピーの北米市場規模2015-2020:アメリカ、カナダ、メキシコ ・ファージセラピーのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど ・ファージセラピーのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど ・ファージセラピーの南米市場規模2015-2020:ブラジル、アルゼンチンなど ・ファージセラピーの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど ・ファージセラピーの種類別市場規模2015-2020:経口、外用、外科的治療 ・ファージセラピーの用途別市場規模2015-2020:人間医学、獣医学、農業 ・ファージセラピーの世界市場予測2021-2025:地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Phage Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Phage Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Phage Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Phage Therapy market has been segmented into:
Oral
External Application
Surgical Treatment
By Application, Phage Therapy has been segmented into:
Human Medicine
Veterinary Science
Agriculture
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Phage Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Phage Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Phage Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Phage Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Phage Therapy Market Share Analysis
Phage Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Phage Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Phage Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Phage Therapy are:
Phage International
Intralytix
C3J Therapeutics
Adaptive Phage Therapeutics
iNtODEWorld
AmpliPhi Biosciences
Phagomed
InnoPhage
Enbiotix
Locus Biosciences
Pherecydes Pharma
Phagelux
TechnoPhage
Eligo Bioscience
1 Phage Therapy Market Overview
1.1 Product Overview and Scope of Phage Therapy
1.2 Classification of Phage Therapy by Type
1.2.1 Global Phage Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Phage Therapy Revenue Market Share by Type in 2019
1.2.3 Oral
1.2.4 External Application
1.2.5 Surgical Treatment
1.3 Global Phage Therapy Market by Application
1.3.1 Overview: Global Phage Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Human Medicine
1.3.3 Veterinary Science
1.3.4 Agriculture
1.4 Global Phage Therapy Market by Regions
1.4.1 Global Phage Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Phage Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Phage Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Phage Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Phage Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Phage Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Phage Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Phage International
2.1.1 Phage International Details
2.1.2 Phage International Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Phage International SWOT Analysis
2.1.4 Phage International Product and Services
2.1.5 Phage International Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Intralytix
2.2.1 Intralytix Details
2.2.2 Intralytix Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Intralytix SWOT Analysis
2.2.4 Intralytix Product and Services
2.2.5 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 C3J Therapeutics
2.3.1 C3J Therapeutics Details
2.3.2 C3J Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 C3J Therapeutics SWOT Analysis
2.3.4 C3J Therapeutics Product and Services
2.3.5 C3J Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Adaptive Phage Therapeutics
2.4.1 Adaptive Phage Therapeutics Details
2.4.2 Adaptive Phage Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Adaptive Phage Therapeutics SWOT Analysis
2.4.4 Adaptive Phage Therapeutics Product and Services
2.4.5 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 iNtODEWorld
2.5.1 iNtODEWorld Details
2.5.2 iNtODEWorld Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 iNtODEWorld SWOT Analysis
2.5.4 iNtODEWorld Product and Services
2.5.5 iNtODEWorld Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 AmpliPhi Biosciences
2.6.1 AmpliPhi Biosciences Details
2.6.2 AmpliPhi Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AmpliPhi Biosciences SWOT Analysis
2.6.4 AmpliPhi Biosciences Product and Services
2.6.5 AmpliPhi Biosciences Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Phagomed
2.7.1 Phagomed Details
2.7.2 Phagomed Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Phagomed SWOT Analysis
2.7.4 Phagomed Product and Services
2.7.5 Phagomed Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 InnoPhage
2.8.1 InnoPhage Details
2.8.2 InnoPhage Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 InnoPhage SWOT Analysis
2.8.4 InnoPhage Product and Services
2.8.5 InnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Enbiotix
2.9.1 Enbiotix Details
2.9.2 Enbiotix Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Enbiotix SWOT Analysis
2.9.4 Enbiotix Product and Services
2.9.5 Enbiotix Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Locus Biosciences
2.10.1 Locus Biosciences Details
2.10.2 Locus Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Locus Biosciences SWOT Analysis
2.10.4 Locus Biosciences Product and Services
2.10.5 Locus Biosciences Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pherecydes Pharma
2.11.1 Pherecydes Pharma Details
2.11.2 Pherecydes Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pherecydes Pharma SWOT Analysis
2.11.4 Pherecydes Pharma Product and Services
2.11.5 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Phagelux
2.12.1 Phagelux Details
2.12.2 Phagelux Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Phagelux SWOT Analysis
2.12.4 Phagelux Product and Services
2.12.5 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 TechnoPhage
2.13.1 TechnoPhage Details
2.13.2 TechnoPhage Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 TechnoPhage SWOT Analysis
2.13.4 TechnoPhage Product and Services
2.13.5 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Eligo Bioscience
2.14.1 Eligo Bioscience Details
2.14.2 Eligo Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Eligo Bioscience SWOT Analysis
2.14.4 Eligo Bioscience Product and Services
2.14.5 Eligo Bioscience Phage Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Phage Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Phage Therapy Players Market Share
3.2.2 Top 10 Phage Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Phage Therapy Revenue and Market Share by Regions
4.2 North America Phage Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Phage Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Phage Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Phage Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Phage Therapy Revenue and Growth Rate (2015-2020)
5 North America Phage Therapy Revenue by Countries
5.1 North America Phage Therapy Revenue by Countries (2015-2020)
5.2 USA Phage Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Phage Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Phage Therapy Revenue and Growth Rate (2015-2020)
6 Europe Phage Therapy Revenue by Countries
6.1 Europe Phage Therapy Revenue by Countries (2015-2020)
6.2 Germany Phage Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Phage Therapy Revenue and Growth Rate (2015-2020)
6.4 France Phage Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Phage Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Phage Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Phage Therapy Revenue by Countries
7.1 Asia-Pacific Phage Therapy Revenue by Countries (2015-2020)
7.2 China Phage Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Phage Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Phage Therapy Revenue and Growth Rate (2015-2020)
7.5 India Phage Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Phage Therapy Revenue and Growth Rate (2015-2020)
8 South America Phage Therapy Revenue by Countries
8.1 South America Phage Therapy Revenue by Countries (2015-2020)
8.2 Brazil Phage Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Phage Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Phage Therapy by Countries
9.1 Middle East & Africa Phage Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Phage Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Phage Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Phage Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Phage Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Phage Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Phage Therapy Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 External Application Revenue Growth Rate (2015-2025)
10.5 Surgical Treatment Revenue Growth Rate (2015-2025)
11 Global Phage Therapy Market Segment by Application
11.1 Global Phage Therapy Revenue Market Share by Application (2015-2020)
11.2 Phage Therapy Market Forecast by Application (2019-2024)
11.3 Human Medicine Revenue Growth (2015-2020)
11.4 Veterinary Science Revenue Growth (2015-2020)
11.5 Agriculture Revenue Growth (2015-2020)
12 Global Phage Therapy Market Size Forecast (2021-2025)
12.1 Global Phage Therapy Market Size Forecast (2021-2025)
12.2 Global Phage Therapy Market Forecast by Regions (2021-2025)
12.3 North America Phage Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Phage Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Phage Therapy Revenue Market Forecast (2021-2025)
12.6 South America Phage Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Phage Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Phage Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Phage Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Phage Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Phage Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Phage International Corporate Information, Location and Competitors
Table 6. Phage International Phage Therapy Major Business
Table 7. Phage International Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 8. Phage International SWOT Analysis
Table 9. Phage International Phage Therapy Product and Solutions
Table 10. Phage International Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Intralytix Corporate Information, Location and Competitors
Table 12. Intralytix Phage Therapy Major Business
Table 13. Intralytix Phage Therapy Total Revenue (USD Million) (2018-2019)
Table 14. Intralytix SWOT Analysis
Table 15. Intralytix Phage Therapy Product and Solutions
Table 16. Intralytix Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. C3J Therapeutics Corporate Information, Location and Competitors
Table 18. C3J Therapeutics Phage Therapy Major Business
Table 19. C3J Therapeutics Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 20. C3J Therapeutics SWOT Analysis
Table 21. C3J Therapeutics Phage Therapy Product and Solutions
Table 22. C3J Therapeutics Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Adaptive Phage Therapeutics Corporate Information, Location and Competitors
Table 24. Adaptive Phage Therapeutics Phage Therapy Major Business
Table 25. Adaptive Phage Therapeutics Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 26. Adaptive Phage Therapeutics SWOT Analysis
Table 27. Adaptive Phage Therapeutics Phage Therapy Product and Solutions
Table 28. Adaptive Phage Therapeutics Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. iNtODEWorld Corporate Information, Location and Competitors
Table 30. iNtODEWorld Phage Therapy Major Business
Table 31. iNtODEWorld Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 32. iNtODEWorld SWOT Analysis
Table 33. iNtODEWorld Phage Therapy Product and Solutions
Table 34. iNtODEWorld Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AmpliPhi Biosciences Corporate Information, Location and Competitors
Table 36. AmpliPhi Biosciences Phage Therapy Major Business
Table 37. AmpliPhi Biosciences Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 38. AmpliPhi Biosciences SWOT Analysis
Table 39. AmpliPhi Biosciences Phage Therapy Product and Solutions
Table 40. AmpliPhi Biosciences Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Phagomed Corporate Information, Location and Competitors
Table 42. Phagomed Phage Therapy Major Business
Table 43. Phagomed Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 44. Phagomed SWOT Analysis
Table 45. Phagomed Phage Therapy Product and Solutions
Table 46. Phagomed Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. InnoPhage Corporate Information, Location and Competitors
Table 48. InnoPhage Phage Therapy Major Business
Table 49. InnoPhage Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 50. InnoPhage SWOT Analysis
Table 51. InnoPhage Phage Therapy Product and Solutions
Table 52. InnoPhage Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Enbiotix Corporate Information, Location and Competitors
Table 54. Enbiotix Phage Therapy Major Business
Table 55. Enbiotix Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 56. Enbiotix SWOT Analysis
Table 57. Enbiotix Phage Therapy Product and Solutions
Table 58. Enbiotix Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Locus Biosciences Corporate Information, Location and Competitors
Table 60. Locus Biosciences Phage Therapy Major Business
Table 61. Locus Biosciences Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 62. Locus Biosciences SWOT Analysis
Table 63. Locus Biosciences Phage Therapy Product and Solutions
Table 64. Locus Biosciences Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Pherecydes Pharma Corporate Information, Location and Competitors
Table 66. Pherecydes Pharma Phage Therapy Major Business
Table 67. Pherecydes Pharma Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 68. Pherecydes Pharma SWOT Analysis
Table 69. Pherecydes Pharma Phage Therapy Product and Solutions
Table 70. Pherecydes Pharma Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Phagelux Corporate Information, Location and Competitors
Table 72. Phagelux Phage Therapy Major Business
Table 73. Phagelux Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 74. Phagelux SWOT Analysis
Table 75. Phagelux Phage Therapy Product and Solutions
Table 76. Phagelux Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. TechnoPhage Corporate Information, Location and Competitors
Table 78. TechnoPhage Phage Therapy Major Business
Table 79. TechnoPhage Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 80. TechnoPhage SWOT Analysis
Table 81. TechnoPhage Phage Therapy Product and Solutions
Table 82. TechnoPhage Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Eligo Bioscience Corporate Information, Location and Competitors
Table 84. Eligo Bioscience Phage Therapy Major Business
Table 85. Eligo Bioscience Phage Therapy Total Revenue (USD Million) (2017-2018)
Table 86. Eligo Bioscience SWOT Analysis
Table 87. Eligo Bioscience Phage Therapy Product and Solutions
Table 88. Eligo Bioscience Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Phage Therapy Revenue (Million USD) by Players (2015-2020)
Table 90. Global Phage Therapy Revenue Share by Players (2015-2020)
Table 91. Global Phage Therapy Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Phage Therapy Revenue Market Share by Regions (2015-2020)
Table 93. North America Phage Therapy Revenue by Countries (2015-2020)
Table 94. North America Phage Therapy Revenue Market Share by Countries (2015-2020)
Table 95. Europe Phage Therapy Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Phage Therapy Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Phage Therapy Revenue by Countries (2015-2020)
Table 98. South America Phage Therapy Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Phage Therapy Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Phage Therapy Revenue Market Share by Countries (2015-2020)
Table 101. Global Phage Therapy Revenue (Million USD) by Type (2015-2020)
Table 102. Global Phage Therapy Revenue Share by Type (2015-2020)
Table 103. Global Phage Therapy Revenue Forecast by Type (2021-2025)
Table 104. Global Phage Therapy Revenue by Application (2015-2020)
Table 105. Global Phage Therapy Revenue Share by Application (2015-2020)
Table 106. Global Phage Therapy Revenue Forecast by Application (2021-2025)
Table 107. Global Phage Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Phage Therapy Picture
Figure 2. Global Phage Therapy Revenue Market Share by Type in 2019
Figure 3. Oral Picture
Figure 4. External Application Picture
Figure 5. Surgical Treatment Picture
Figure 6. Phage Therapy Revenue Market Share by Application in 2019
Figure 7. Human Medicine Picture
Figure 8. Veterinary Science Picture
Figure 9. Agriculture Picture
Figure 10. Global Phage Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Phage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Phage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Phage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Phage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Phage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Phage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Phage Therapy Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Phage Therapy Revenue Market Share in 2019
Figure 19. Global Top 10 Players Phage Therapy Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Phage Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Phage Therapy Revenue Market Share by Regions (2015-2020)
Figure 23. Global Phage Therapy Revenue Market Share by Regions in 2018
Figure 24. North America Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 25. Europe Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 27. South America Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 29. North America Phage Therapy Revenue Market Share by Countries (2015-2020)
Figure 30. North America Phage Therapy Revenue Market Share by Countries in 2019
Figure 31. USA Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Canada Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Europe Phage Therapy Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Phage Therapy Revenue Market Share by Countries in 2019
Figure 36. Germany Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 37. UK Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 38. France Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Russia Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Italy Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Phage Therapy Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Phage Therapy Revenue Market Share by Countries in 2019
Figure 43. China Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 44. Japan Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Korea Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 46. India Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 48. South America Phage Therapy Revenue Market Share by Countries (2015-2020)
Figure 49. South America Phage Therapy Revenue Market Share by Countries in 2019
Figure 50. Brazil Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Phage Therapy Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Phage Therapy Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 55. UAE Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Phage Therapy Revenue and Growth Rate (2015-2020)
Figure 58. Global Phage Therapy Revenue Share by Type (2015-2020)
Figure 59. Global Phage Therapy Revenue Share by Type in 2019
Figure 60. Global Phage Therapy Market Share Forecast by Type (2021-2025)
Figure 61. Global Oral Revenue Growth Rate (2015-2020)
Figure 62. Global External Application Revenue Growth Rate (2015-2020)
Figure 63. Global Surgical Treatment Revenue Growth Rate (2015-2020)
Figure 64. Global Phage Therapy Revenue Share by Application (2015-2020)
Figure 65. Global Phage Therapy Revenue Share by Application in 2019
Figure 66. Global Phage Therapy Market Share Forecast by Application (2021-2025)
Figure 67. Global Human Medicine Revenue Growth Rate (2015-2020)
Figure 68. Global Veterinary Science Revenue Growth Rate (2015-2020)
Figure 69. Global Agriculture Revenue Growth Rate (2015-2020)
Figure 70. Global Phage Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Phage Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Phage Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Phage Therapy Revenue Market Forecast (2021-2025)
Figure 74. Europe Phage Therapy Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Phage Therapy Revenue Market Forecast (2021-2025)
Figure 76. South America Phage Therapy Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Phage Therapy Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel